These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3373590)

  • 1. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin: initial treatment results and the long-term course.
    Lundbeck F; Bruun E; Finnerup B; Christophersen IS
    J Urol; 1988 Jun; 139(6):1212-3. PubMed ID: 3373590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH; Lee C
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and treatment of low and high risk superficial bladder tumors.
    Rübben H; Lutzeyer W; Fischer N; Deutz F; Lagrange W; Giani G
    J Urol; 1988 Feb; 139(2):283-5. PubMed ID: 3339726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
    Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
    Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.
    Flamm J
    Eur Urol; 1990; 17(2):119-24. PubMed ID: 2178939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
    Li NC; Ye ZQ; Na YQ;
    Chin Med J (Engl); 2013; 126(15):2805-9. PubMed ID: 23924446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter study. Blinst Italian Cooperative Group.
    Cancer; 1984 Aug; 54(4):756-61. PubMed ID: 6378357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin and urokinase.
    Lundbeck F; Mogensen P; Jeppesen N
    J Urol; 1983 Dec; 130(6):1087-9. PubMed ID: 6644887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrences during the chemoprophylactic treatment of superficial tumors of the bladder.
    Ferraris V; Repetto E; Pisano PF; Albano D
    J Urol; 1986 Sep; 136(3):576-9. PubMed ID: 3735530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insignificant role of bacillus Calmette-Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.
    Nakai Y; Anai S; Tanaka N; Chihara Y; Haramoto M; Otani T; Nakagawa Y; Hirao Y; Konishi N; Fujimoto K
    Int J Urol; 2016 Oct; 23(10):854-860. PubMed ID: 27416975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial.
    Tsushima T; Ohmori H; Ohi Y; Shirahama T; Kawahara M; Matsumura Y; Ohashi Y
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S69-75. PubMed ID: 7994791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive series.
    Ausfeld R; Beer M; Mühlethaler JP; Bartlome F; Widmer R; Tscholl R
    Eur Urol; 1987; 13(1-2):10-4. PubMed ID: 3582437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.